Skip to main content
Recordati Industria Chimica e Farmaceutica S.p.A. (BIT: REC)
Italy flag Italy · Delayed Price · Currency is EUR
54.60
-0.30 (-0.55%)
Jan 20, 2025, 5:36 PM CET

BIT: REC Revenue

Recordati Industria Chimica e Farmaceutica had revenue of 557.41M EUR in the quarter ending September 30, 2024, with 8.89% growth. This brings the company's revenue in the last twelve months to 2.27B, up 11.68% year-over-year. In the year 2023, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.08B with 12.36% growth.

Revenue (ttm)
2.27B
Revenue Growth
+11.68%
P/S Ratio
4.96
Revenue / Employee
509.37K
Employees
4,455
Market Cap
11.16B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.08B229.02M12.36%
Dec 31, 20221.85B273.23M17.29%
Dec 31, 20211.58B131.21M9.06%
Dec 31, 20201.45B-32.98M-2.23%
Dec 31, 20191.48B129.61M9.59%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Amplifon 2.36B
DiaSorin 1.18B
EL.En. 665.50M
Philogen 3.92M
Pharmanutra 113.13M
Safilo Group 1.01B
GPI S.p.A. 484.01M
Shedir Pharma Group 60.96M
Revenue Rankings

Recordati Industria Chimica e Farmaceutica News

More News